These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 22290263)
41. Targeting cancer stem cells for treatment of glioblastoma multiforme. Cho DY; Lin SZ; Yang WK; Lee HC; Hsu DM; Lin HL; Chen CC; Liu CL; Lee WY; Ho LH Cell Transplant; 2013; 22(4):731-9. PubMed ID: 23594862 [TBL] [Abstract][Full Text] [Related]
42. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties. Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656 [TBL] [Abstract][Full Text] [Related]
43. The role of cancer stem cells in glioblastoma. Sundar SJ; Hsieh JK; Manjila S; Lathia JD; Sloan A Neurosurg Focus; 2014 Dec; 37(6):E6. PubMed ID: 25434391 [TBL] [Abstract][Full Text] [Related]
44. Epigenetic regulation of cancer stem cell and tumorigenesis. Zhu K; Xie V; Huang S Adv Cancer Res; 2020; 148():1-26. PubMed ID: 32723561 [TBL] [Abstract][Full Text] [Related]
45. Emerging therapeutic targets and agents for glioblastoma migrating cells. Di C; Mattox AK; Harward S; Adamson C Anticancer Agents Med Chem; 2010 Sep; 10(7):543-55. PubMed ID: 20950259 [TBL] [Abstract][Full Text] [Related]
46. Wnt5a Drives an Invasive Phenotype in Human Glioblastoma Stem-like Cells. Binda E; Visioli A; Giani F; Trivieri N; Palumbo O; Restelli S; Dezi F; Mazza T; Fusilli C; Legnani F; Carella M; Di Meco F; Duggal R; Vescovi AL Cancer Res; 2017 Feb; 77(4):996-1007. PubMed ID: 28011620 [TBL] [Abstract][Full Text] [Related]
47. Advances in histone deacetylase inhibitors in targeting glioblastoma stem cells. Reddy RG; Bhat UA; Chakravarty S; Kumar A Cancer Chemother Pharmacol; 2020 Aug; 86(2):165-179. PubMed ID: 32638092 [TBL] [Abstract][Full Text] [Related]
48. Overcoming therapeutic resistance in glioblastoma: the way forward. Osuka S; Van Meir EG J Clin Invest; 2017 Feb; 127(2):415-426. PubMed ID: 28145904 [TBL] [Abstract][Full Text] [Related]
49. Glioblastoma multiforme: a glance at advanced therapies based on nanotechnology. Rezaei V; Rabiee A; Khademi F J Chemother; 2020 May; 32(3):107-117. PubMed ID: 31984871 [TBL] [Abstract][Full Text] [Related]
50. Let the Guard Down: cAMP Activators Can Improve Immunotherapy in GBM. Lee J; Kay KE; Vogelbaum MA; Lathia JD Cancer Immunol Res; 2023 Oct; 11(10):1300-1301. PubMed ID: 37702792 [TBL] [Abstract][Full Text] [Related]
51. Application of microfluidic devices for glioblastoma study: current status and future directions. Cai X; Briggs RG; Homburg HB; Young IM; Davis EJ; Lin YH; Battiste JD; Sughrue ME Biomed Microdevices; 2020 Sep; 22(3):60. PubMed ID: 32870410 [TBL] [Abstract][Full Text] [Related]
55. In vitro demonstration of salinomycin as a novel chemotherapeutic agent for the treatment of SOX2‑positive glioblastoma cancer stem cells. Magrath JW; Raney WR; Kim Y Oncol Rep; 2020 Aug; 44(2):777-785. PubMed ID: 32627023 [TBL] [Abstract][Full Text] [Related]
56. Tropism of mesenchymal stem cell toward CD133 Pavon LF; Sibov TT; de Souza AV; da Cruz EF; Malheiros SMF; Cabral FR; de Souza JG; Boufleur P; de Oliveira DM; de Toledo SRC; Marti LC; Malheiros JM; Paiva FF; Tannús A; de Oliveira SM; Chudzinski-Tavassi AM; de Paiva Neto MA; Cavalheiro S Stem Cell Res Ther; 2018 Nov; 9(1):310. PubMed ID: 30413179 [TBL] [Abstract][Full Text] [Related]
57. Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine. Kim SS; Harford JB; Pirollo KF; Chang EH Biochem Biophys Res Commun; 2015 Dec; 468(3):485-9. PubMed ID: 26116770 [TBL] [Abstract][Full Text] [Related]
58. Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors. Liu Q; Nguyen DH; Dong Q; Shitaku P; Chung K; Liu OY; Tso JL; Liu JY; Konkankit V; Cloughesy TF; Mischel PS; Lane TF; Liau LM; Nelson SF; Tso CL J Neurooncol; 2009 Aug; 94(1):1-19. PubMed ID: 19468690 [TBL] [Abstract][Full Text] [Related]